Nordic Life Science Days’ Post

We recently hosted a session at Nordic Life Science Days 2024, where industry leaders gathered to discuss the challenges and opportunities in advancing patient centricity within the pharmaceutical sector.   Despite the ongoing efforts across the industry to address patient needs throughout drug discovery, development, and commercialization, significant gaps remain. These challenges include identifying unmet needs early on, navigating increasingly complex clinical trials, and ensuring product availability.   Dr. Ulrica Sehlstedt, Arthur D. Little’s Global Leader for the Healthcare & Life Sciences practice, moderated a panel featuring Christophe Bourdon, CEO of LEO Pharma; Kati Kaijasilta, Business Development Director at Orion Pharma Ltd; Mike Ryan, General Manager Europe at EVERSANA; and Dr. Holger Kissel, Senior Vice President Scientific Relations and Liaison at BioNTech SE. Together, they explored how leading pharmaceutical companies are working to overcome these challenges to enhance patient value and achieve commercial success.   The discussions were insightful, and while we are encouraged by the innovative progress being made, it is clear there is still much work ahead. We look forward to continuing to collaborate across the industry to drive further improvements for patients.   #NLSDays #HealthcareInnovation #PatientCentricity